Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Bioabsorbable Stents Market Is Expected To Generate Huge Profits by 2021

 



(PharmaNewsWire.Com, January 07, 2017 ) Stents are commonly used in the treatment of blocked arteries. They are tiny and expandable mesh tubes that hold arteries open and help treat coronary and peripheral artery diseases. Bioabsorbable stents are defined as fully biodegradable stents that completely disappear overtime.

Bioabsorbable stents can be broadly classified into two main types: polymeric bioabsorbable stents and metallic alloy bioabsorbable stents. Polymeric bioabsorbable stents are widely used in cardiovascular devices. Polymers used in bioabsorbable stents are Poly-L-Lactic acid (PLLA), Poly (D, L-lactide/glycolide) copolymer (PDLA), Polyglycolic Acid (PGA), and polycaprolactone. Usage of bioabsorbable polymer coating reduces the need for extended dual anti-platelet therapy and reduces thrombotic events. Poly-L-Lactic acid is widely used in medicine and breaks down lactic acid into natural metabolites in the human body. After that, Poly-L-Lactic acid enters into Krebs cycle and metabolized carbon dioxide and water.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/3827

Iron and magnesium are the most frequently used metal alloys used to make metallic bioabsorbable stents. Factors that determine the biocompatibility of these metal alloys are their solubility and degradation products. Magnesium bioabsorbable stents are the most commonly used metallic alloy stents in disease management as magnesium is an essential element of the human body. It induces rapid endothelialization and lowers thrombogenicity. Magnesium bioabsorbable stents have a lower degradation time of about 2 – 3 months compared to iron-based bioabsorbale stents.

Geographically, North America dominates the global bioabsorbable stents market owing to the increased awareness about the important role played by bioabsorbable stents in the treatment of coronary ailments in the region. In addition, technological advancements in bioabsorbable stents products is also supporting in the growth of this market in North America. The U.S. represents the largest market for bioabsorbable stents, followed by Canada, in North America. In Europe, Germany, Italy, the U.K., and France holds major shares of the bioabsorbable stents market. However, Asia is expected to exhibit a high growth rate in the next five years in the global bioabsorbable stents market given the increasing public awareness about various coronary and peripheral artery diseases in the region. Japan, China, and India are expected to be the fastest growing bioabsorbable stents markets in Asia.

In recent times, increasing prevalence of coronary and peripheral artery diseases is the key driver of the global bioabsorbable stents market. Bioabsorbable stents avoid stent-in-stent procedures. They also eliminate the need for dual anti-platelet therapies and treat coronary artery diseases more effectively. Accurate stent placement and low cost treatment also attract patients to adopt bioabsorbable stents for disease management.

However, slow adoption rate of stents in disease management is the key restraint faced by the global bioabsorbable stents market. High risks of complications associated with bioabsorbable stents and high selling price also hampers the market growth. In addition, inadequate reimbursement policies and presence of substitutes are some of the major challenges faced by the global bioabsorbable stents market. Rising number of product launches and increasing mergers and acquisitions between key players are key trends of this market.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/3827

Major companies operating in the global bioabsorbable stents market are Abbott Laboratories, Arterial Remodeling Technologies SA, Amaranth Medical, Inc., BIOTRONIK SE & Co. KG, REVA Medical, Inc., Kyoto Medical Planning, Co., Ltd., and Elixir Medical Corporation.

Persistence Market Research

Rahul Singh

+1-646-568-7751

rahul@persistencemarketresearch.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC